Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
61.34
-1.96 (-3.10%)
At close: Aug 20, 2026, 4:00 PM EDT
61.61
+0.27 (0.44%)
Pre-market: Aug 21, 2026, 7:16 AM EDT

Vaxcyte Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
183.19173.96387.88397.45834.6668.99
Short-Term Investments
1,3041,3871,359682.7896.72176.99
Cash & Short-Term Investments
1,4871,5611,7471,080931.38245.97
Cash Growth
-10.51%-10.66%61.75%15.98%278.65%-36.31%
Other Receivables
-46.5623.083.63.881.2
Receivables
-46.5623.083.63.881.2
Prepaid Expenses
65.8317.0415.736.165.319.18
Other Current Assets
-2.81.965.971.99-
Total Current Assets
1,5531,6271,7881,096942.56256.35
Property, Plant & Equipment
370.57373.38270.15110.6231.6535.91
Long-Term Investments
1,021881.661,388162.6826.5527.12
Long-Term Deferred Charges
-----0.5
Other Long-Term Assets
194.02120.3165.6838.675.434.46
Total Assets
3,1383,0033,5111,4081,006324.34

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
100.9270.948.4514.599.86.76
Accrued Expenses
163.85128.7285.84123.6424.8216.68
Current Portion of Leases
6.516.125.897.115.915.28
Total Current Liabilities
271.28205.75140.18145.3440.5328.72
Long-Term Leases
108.94111.3665.2222.1112.0311.51
Other Long-Term Liabilities
-0.10.1-0.010.1
Total Liabilities
380.21317.21205.5167.4552.5740.32

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.150.130.130.10.080.06
Additional Paid-In Capital
5,5254,8394,6982,1651,476582.84
Retained Earnings
-2,760-2,155-1,388-924.39-522.13-298.64
Comprehensive Income & Other
-7.551.59-3.870.18-0.36-0.24
Total Common Equity
2,7582,6863,3061,240953.61284.02
Shareholders' Equity
2,7582,6863,3061,240953.61284.02
Total Liabilities & Equity
3,1383,0033,5111,4081,006324.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
115.45117.4871.1129.2217.9416.78
Net Cash (Debt)
1,3711,4431,6761,051913.44229.19
Net Cash Growth
-12.96%-13.88%59.48%15.06%298.55%-40.66%
Net Cash Per Share
9.8510.6113.7410.8214.084.41
Filing Date Shares Outstanding
148.81143.92128.76108.4180.0356.31
Total Common Shares Outstanding
144.79131.06124.8995.3679.4753.03
Working Capital
1,2811,4221,648950.62902.03227.63
Book Value Per Share
19.0520.4926.4713.0112.005.36
Tangible Book Value
2,7582,6863,3061,240953.61284.02
Tangible Book Value Per Share
19.0520.4926.4713.0112.005.36
Machinery
-65.8258.1535.6215.1211.5
Construction In Progress
-217.08151.7951.82--
Leasehold Improvements
-7.244.381.461.35-
SEC Filings: 10-K · 10-Q